Apalutamide will lower the extent or outcome of ethinylestradiol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Stay clear of or Use Alternate Drug. Coadministration of apalutamide, a solid CYP3A4 inducer, with medications which can be CYP3A4 substrates can result in decreased exposure to these prescription drugs. 1. Acquire the initial "Lively" https://genej741vwx7.levitra-wiki.com/user